Robert Terkeltaub

Active 1983–2025

161
Papers
24,104
Citations
94
h-index
155
i10-index

Citations

Citations per year for Robert Terkeltaub1985: 1 citations1986: 2 citations1988: 1 citations1989: 4 citations1990: 2 citations1991: 6 citations1992: 10 citations1993: 26 citations1994: 23 citations1995: 28 citations1996: 26 citations1997: 26 citations1998: 54 citations1999: 70 citations2000: 84 citations2001: 95 citations2002: 95 citations2003: 138 citations2004: 165 citations2005: 200 citations2006: 200 citations2007: 180 citations2008: 201 citations2009: 169 citations2010: 245 citations2011: 239 citations2012: 278 citations2013: 239 citations2014: 233 citations2015: 197 citations2016: 237 citations2017: 211 citations2018: 174 citations2019: 615 citations2020: 780 citations2021: 615 citations2022: 591 citations2023: 434 citations2024: 735 citations2025: 360 citations2026: 13 citations1987: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,971 citing papers, 24.4% of this breakdownChina: 1,267 citing papers, 15.7% of this breakdownUnited Kingdom: 453 citing papers, 5.6% of this breakdownGermany: 383 citing papers, 4.7% of this breakdownItaly: 330 citing papers, 4.1% of this breakdownJapan: 280 citing papers, 3.5% of this breakdownFrance: 276 citing papers, 3.4% of this breakdownCanada: 267 citing papers, 3.3% of this breakdownNetherlands: 255 citing papers, 3.2% of this breakdownAustralia: 232 citing papers, 2.9% of this breakdownSpain: 199 citing papers, 2.5% of this breakdownSwitzerland: 162 citing papers, 2% of this breakdown
0%24.4%Other 24.7%

Fields

  • Medicine65.4%
  • Biochemistry, Genetics and Molecular Biology20.4%
  • Immunology and Microbiology7.7%
  • Neuroscience1.2%
  • Engineering1%
  • Nursing0.9%
  • Other3.4%

Topics

  • Gout, Hyperuricemia, Uric Acid9.3%
  • Osteoarthritis Treatment and Mechanisms5.9%
  • Inflammasome and immune disorders4.3%
  • Thyroid Disorders and Treatments2.3%
  • Atherosclerosis and Cardiovascular Diseases2%
  • Parathyroid Disorders and Treatments1.9%
  • Other74.3%

Coauthors

All papers

Open in search
  1. Emerging regulators of the inflammatory process in osteoarthritis

    Authors: , - Nature Reviews Rheumatology 2014 cited by 644

  2. Mitochondrial Biogenesis Is Impaired in Osteoarthritis Chondrocytes but Reversible via Peroxisome Proliferator–Activated Receptor γ Coactivator 1α

    Authors: , , , , - Arthritis & Rheumatology 2015 cited by 302

  3. Association Between Gut Microbiota and Elevated Serum Urate in Two Independent Cohorts

    Authors: , , , , , , , , , , - Arthritis & Rheumatology 2021 cited by 133

  4. Choline Uptake and Metabolism Modulate Macrophage IL-1β and IL-18 Production

    Authors: , , , , , , , , , , , , , , - Cell Metabolism 2019 cited by 263

  5. Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout

    Authors: , , , , , , , , , , - Arthritis & Rheumatology 2021 cited by 123

  6. 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark L. Robbins, Neil S. Wenger, Robert Terkeltaub - Arthritis Care & Research 2012 cited by 1,535

  7. Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease

    Authors: , , , , , , , , , , - The American Journal of Medicine 2021 cited by 122

  8. Enhancing untargeted metabolomics using metadata-based source annotation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clarisse Marotz, Kate E. Sprecher, Daniela Vargas-Robles, Dana Withrow, Gail Ackermann, Lourdes Herrera, B.J. Bradford, Lucas Maciel Mauriz Marques, Juliano Geraldo Amaral, Rodrigo Moreira da Silva, Flávio P. Veras, Thiago M. Cunha, Renê Donizeti Ribeiro de Oliveira, Paulo Louzada‐Júnior, Robert H. Mills, Paulina K. Piotrowski, Stephanie L. Servetas, Sandra M. Da Silva, Christina M. Jones, Nancy J. Lin, Katrice A. Lippa, Scott A. Jackson, Rima Kaddurah Daouk, Douglas Galasko, Parambir S. Dulai, Tatyana Kalashnikova, Curt Wittenberg, Robert Terkeltaub, Megan M. Doty, Jae Kim, Kyung E. Rhee, Julia Beauchamp‐Walters, Kenneth P. Wright, Maria Gloria Domínguez-Bello, Mark Manary, Michelli F. Oliveira, Brigid S. Boland, Norberto Peporine Lopes, Mónica Gumá, Austin D. Swafford, Rachel J. Dutton, Rob Knight, Pieter C. Dorrestein - Nature Biotechnology 2022 cited by 77

  9. Update on gout: new therapeutic strategies and options

    Authors: - Nature Reviews Rheumatology 2010 cited by 393

  10. Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management

    Authors: , , , , , , , , , , , , , , , , - NEJM Evidence 2022 cited by 100

  11. Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities

    Authors: , , , , , , , , , - Nature Reviews Rheumatology 2021 cited by 94

  12. High versus low dosing of oral colchicine for early acute gout flare: Twenty‐four–hour outcome of the first multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, dose‐comparison colchicine study

    Authors: , , , , , - Arthritis & Rheumatism 2010 cited by 530

  13. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helena de Almeida Tupinambá, Hisashi Yamanaka, Hyon K. Choi, James Mackay, James R. O’Dell, Janitzia Vázquez Mellado, Jasvinder A. Singh, John FitzGerald, L. Jacobsson, Leo A. B. Joosten, Leslie R. Harrold, Lisa K. Stamp, Mariano Andrés, Marwin Gutiérrez, Masanari Kuwabara, Mats Dehlin, M. Janssen, Michael Doherty, Michael S. Hershfield, Michael H. Pillinger, N. Lawrence Edwards, Naomi Schlesinger, Nitin Kumar, Ole Slot, Sébastien Ottaviani, Pascal Richette, Paul MacMullan, Peter T. Chapman, Peter E. Lipsky, Philip C. Robinson, Puja Khanna, Rada Gancheva, Rebecca Grainger, Richard J. Johnson, Ritch te Kampe, Robert T. Keenan, Sara K. Tedeschi, Seoyoung C. Kim, Sung Jae Choi, Theodore Fields, Thomas Bardin, Till Uhlig, Tim Jansen, Tony R. Merriman, Tristan Pascart, Tuhina Neogi, Viola Klück, Worawit Louthrenoo, Nicola Dalbeth - Annals of the Rheumatic Diseases 2019 cited by 119

  14. Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review

    Authors: - Drugs 2023 cited by 89

  15. Innate immunity conferred by toll‐like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal–induced inflammation

    Authors: , , , , - Arthritis & Rheumatism 2005 cited by 408

  16. The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Uri Arad, Thanda Aung, Eva Benillouche, Alessandra Bortoluzzi, Jonathan Dau, Ernest Maningding, Meika A. Fang, F. Figus, Emilio Filippucci, Janine Haslett, M. Janssen, Marian Kaldas, Maryann Kimoto, Kelly Leamy, Geraldine M. Navarro, Piercarlo Sarzi‐Puttini, Carlo Alberto Scirè, Ettore Silvagni, Silvia Sirotti, John Stack, Linh Truong, Chen Xie, Chio Yokose, Alison M. Hendry, Robert Terkeltaub, William J. Taylor, Hyon K. Choi - Annals of the Rheumatic Diseases 2023 cited by 69

  17. Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2003 cited by 603

  18. A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares

    Authors: , , , , , , , , , , - Arthritis & Rheumatology 2021 cited by 87

  19. 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark L. Robbins, Neil S. Wenger, Robert Terkeltaub - Arthritis Care & Research 2012 cited by 731

  20. Activation of AMPK-SIRT3 signaling is chondroprotective by preserving mitochondrial DNA integrity and function

    Authors: , , , - Osteoarthritis and Cartilage 2018 cited by 126

  21. The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Uri Arad, Thanda Aung, Eva Benillouche, Alessandra Bortoluzzi, Jonathan Dau, Ernest Maningding, Meika A. Fang, F. Figus, Emilio Filippucci, Janine Haslett, M. Janssen, Marian Kaldas, Maryann Kimoto, Kelly Leamy, Geraldine M. Navarro, Piercarlo Sarzi‐Puttini, Carlo Alberto Scirè, Ettore Silvagni, Silvia Sirotti, John Stack, Linh Truong, Chen Xie, Chio Yokose, Alison M. Hendry, Robert Terkeltaub, William J. Taylor, Hyon K. Choi - Arthritis & Rheumatology 2023 cited by 73

  22. Monosodium urate crystals regulate a unique JNK-dependent macrophage metabolic and inflammatory response

    Authors: , , , , , , , , , , , , - Cell Reports 2022 cited by 72

  23. Cartilage cell clusters

    Authors: , , , , , - Arthritis & Rheumatism 2010 cited by 236

  24. Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior

    Authors: , , , , , , , , , , , , , - Arthritis Research & Therapy 2020 cited by 91